Physician profile
Hayden Smith
NPI 1366947004
$2,175.44
in general payments reported to CMS, 2019-2025
16 companies · $496 in 2025
The $496 reported for 2025 was more than what 79% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $65.29 · 2022: $146 · 2023: $666 · 2024: $802 · 2025: $496.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,964.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,964.16 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $946.52 | 2023-2025 | Botox, Ubrelvy |
| Merz Pharmaceuticals, LLC | $479.89 | 2022-2024 | Xeomin |
| Ipsen Biopharmaceuticals, INC | $289.92 | 2022-2025 | Dysport |
| Medtronic, INC. | $100.48 | 2022-2025 | Synchromedii, Intellis Adaptivestim |
| Saol Therapeutics INC. | $65.29 | 2020 | |
| Amneal Pharmaceuticals LLC | $64.57 | 2023 | Lyvispah |
| Lundbeck LLC | $45.06 | 2024-2025 | Vyepti |
| Microtransponder, INC. | $39.18 | 2024-2025 | |
| Avanir Pharmaceuticals, INC. | $23.70 | 2022 | |
| Piramal Critical Care | $20.56 | 2023 | |
| Electronic Waveform Lab, INC. | $19.51 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $19.14 | 2023 | Nuedexta |
| Neuros Medical, INC. | $16.66 | 2025 | Altius |
| Ossur Americas, INC. | $15.99 | 2025 | |
| Ibsa Pharma INC. | $14.78 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $14.19 | 2024 | L300 Go System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hayden Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.